The Subchronic Effects of the TRH Analog TA‐0910 and Bromocriptine on Alcohol Preference in Alcohol‐Preferring Rats: Development of Tolerance and Cross‐Tolerance

Alcoholism: Clinical and Experimental Research

Volumn 18, Issue 5, 1994, Pages 1196-1201

  Mason, George A ^a   Rezvani, Amir H ^a   Grady, Danny R ^a   Garbutt, James C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol Preference; Bromocriptine; Rats; Tolerance; TRH Analog

Indexed keywords

BROMOCRIPTINE; TALTIRELIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CROSS TOLERANCE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; DRUG TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ALCOHOLISM; ANIMAL; BROMOCRIPTINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; INJECTIONS, SUBCUTANEOUS; MALE; PROTIRELIN; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA;

EID: 0027945991     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1994.tb00104.x     Document Type: Article

References (44)

1. Inheritance of alcohol abuse
2. Neurogenetic adaptive mechanisms in alcoholism
3. New strains of rats with alcohol preference and nonpreference
4. Induction of dependence on ethanol by free choice drinking in alcohol‐preferring rats
5. Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats
6. Administration of thyrotropin releasing bormone (TRH) to rats releases dopamine in n. accumbens but not in n. caudatus
7. Pharmacology of thyrotropin‐releasing hormone
8. Behavioral effects of hypothalamic hypophysiotropic hormones, neurotensin, substance P and other neuropeptides
9. Pharmacological study of TA‐0910, a new thyrotropin‐releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA‐0910
10. Synthesis and central nervous system actions of thyrotropin‐releasing hormone analogues containing a dihydroorotic acid moiety
11. Attenuation of alcohol preference in alcohol‐preferning rats by a novel TRH analogue, TA‐0910
12. Genetic serotonin deficiency and alcohol preference in the fawn hooded rat
13. Drug‐induced reductions in ethanol intake in alcohol preferring and fawn‐hooded rats
14. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonists SCH 2339D administration in rats
15. Bromocriptine reverses the elevation in intracranial self‐stimulation thresholds observed in a rat model of cocaine withdrawal
16. Regulation of thyrotropin releasing hormone degrading enzymes in rat brain and pituitary by L‐3,5,3′‐triiodothyronine
17. Degradation of thyrotropin‐releasing hormone and luteinizing hormone by enzymes of brain tissue
18. Regulation and cellular localization of the membrane‐bound thyrotropin‐releasing hormone‐degrading enzyme in primary cultures of neuronal, glial and adenohypophyseal cells
19. Inhibition of pyroglutamyl peptidase II synthesis by phorbal ester in the retinoblastoma cell
20. Treatment of rats with the TRH analog MK‐771
21. Iodothyronine homeostasis in rat brain during hypo‐ and hyperthyroidism
22. Effect of acute and chronic triiodothyronine (T3) administration to rats on central 5‐HT and dopamine‐mediated behavioural responses and related brain biochemistry
23. Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status
24. Post‐synaptic changes and increased dopamine receptor sensitivity in hypothyroid rats
25. Cellular and molecular mechanisms of drug dependence
26. Serotonin uptake blockers and the treatment of alcoholism
27. Long‐lasting suppression of alcohol preference in rats following serotonin receptor blockade by ritanserin
28. 5‐HT and alcohol abuse
29. Suppression of alcohol consumption by fenfluramine in Fawn‐hooded rats with serotonin dysfunction
30. Reduction in ethanol preference following injection of centrally and peripherally acting antimuscarinic agents
31. Structure activity relationship studies with hypothalamic peptide hormones. II. Effects of thyrotropin releasing hormone analogs on morphine‐induced responses in mice
32. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations
33. Naltrex‐one in the treatment of alcohol dependence
34. Naltrexone and coping skills therapy for alcohol dependence
35. Effects of YM‐14673, a new TRH analogue, on responses to morphine in rodents
36. Interaction of TRH and opiates at the level of their respective brain receptors
37. TRH (lopremone): Psychobiological responses in normal women. I. Subjective experiences
38. Improvement in ratings of tension after TRH administration in healthy women
39. Thyrotropin‐releasing hormone antagonism of ethanol inebriation
40. Behavioral and endocrine interactions between thyrotropin‐releasing hormone and ethanol in normal human subjects
41. Failure of TRH and ORG 2766 hexapeptide to counteract alcoholic inebriation in man
42. Attenuation of the effect of punishment by thyrotropin‐releasing hormone: comparisons with chlordiazepoxide
43. Potentiation of the behavioral effects of pentobarbital, chlordiazepoxide and ethanol by thyrotropin‐releasing hormone
44. Tolerance and anti‐craving drug effectiveness for alcohol